Ernexa Therapeutics Inc.
ERNA
$0.208
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.76M | -26.60M | -5.53M | -6.65M | -6.15M |
| Total Depreciation and Amortization | 68.00K | 451.00K | 578.00K | 541.00K | 481.00K |
| Total Amortization of Deferred Charges | 3.11M | 1.23M | 474.00K | 445.00K | 251.00K |
| Total Other Non-Cash Items | 461.00K | 21.92M | 466.00K | 934.00K | 292.00K |
| Change in Net Operating Assets | -1.43M | -3.28M | 1.75M | 980.00K | 468.00K |
| Cash from Operations | -3.55M | -6.29M | -2.26M | -3.75M | -4.66M |
| Capital Expenditure | 0.00 | -19.00K | -249.00K | -101.00K | -19.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 4.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -19.00K | -249.00K | -97.00K | -19.00K |
| Total Debt Issued | 0.00 | 3.89M | 0.00 | 1.41M | 9.29M |
| Total Debt Repaid | -- | -- | -- | -- | -1.50M |
| Issuance of Common Stock | 1.14M | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.00 | -8.00K | -- | -8.00K |
| Other Financing Activities | -135.00K | 0.00 | -14.00K | -20.00K | -76.00K |
| Cash from Financing | 1.01M | 3.89M | -22.00K | 1.39M | 7.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.54M | -2.42M | -2.53M | -2.46M | 3.02M |